Know What's Happening in Healthcare
Know What's Happening in Healthcare
KKR and GIC delay sale of 80% stake in Philippines’ Metro Pacific Health
Private equity firm KKR and Singapore sovereign‑wealth fund GIC have postponed the sale of their combined 80% stake in Metro Pacific Health, the Philippines’ largest private hospital group. The delay is due to an inability to secure a valuation that meets investor expectations, a challenge worsened by geopolitical uncertainty from the Iran conflict. Metro Pacific Health, which retains a 20% stake, had hoped to acquire an additional share as part of the transaction.
Also developing:
By the numbers: Syneron Bio raises $150M Series B
Vision loss remains a leading disability, prompting biotech firms to shift from symptom‑management to disease‑modifying therapies. Gene‑replacement approaches using AAV vectors dominate the inherited retinal disease pipeline, highlighted by Luxturna’s success and multiple late‑stage candidates such as Beacon’s laru‑zova and Ocugen’s OCU400. Cell‑based platforms like Neurotech’s Encelto and jCyte’s jCell add regenerative options, while bispecific antibodies aim to improve outcomes for wet AMD and diabetic macular edema. The sector is attracting billions in capital as investors chase curative potential.
On November 20, 2020, Verb and Johnson & Johnson unveiled OTTAVA, a six‑armed robotic platform designed for minimally invasive surgery. The system integrates AI‑driven vision, haptic feedback, and modular tooling to automate complex suturing and tissue manipulation. Early trials report a 30%...
Livi, Europe’s leading digital‑first healthcare provider, has partnered with AI‑driven holistic platform CloudFit to launch an integrated preventative health solution. The collaboration lets Livi GPs refer patients to CloudFit’s fitness, nutrition and lifestyle coaching, creating a continuous care loop between...
The 2021 Consolidated Appropriations Act introduced mandatory broker compensation disclosures and broader pricing data for health plans, pushing plan sponsors to adopt fiduciary rigor similar to retirement plans. Yet, translating transparency into cost control remains difficult as procedure prices can...
Washington University in St. Louis deployed a clinical decision‑support workflow to curb over‑ordering of inpatient magnesium tests, a high‑volume assay often ordered by default on daily order sets. Analysis of Epic data showed half of the orders were routine "AM...
A wave of clinical trials is testing stem‑cell, gene‑editing and bionic‑eye technologies to treat blindness, especially retinitis pigmentosa and dry age‑related macular degeneration. Early‑stage studies from UC Davis, BlueRock Therapeutics and the University of Michigan report measurable vision gains, such as...
Ipca Laboratories posted a robust 19% year‑on‑year EBITDA increase to ₹530 crore, surpassing broker estimates, while revenue rose 6.6% to ₹2,400 crore. Domestic formulation sales grew 12% and export formulation climbed 17%, offset by flat API sales overall but a 26% rebound...
Recent high‑profile sexual‑abuse scandals, such as the Jeffrey Epstein case, are prompting a wave of trauma reactivation among survivors who had previously kept their experiences hidden. Patients often present with insomnia, irritability, increased alcohol use, or vague anxiety that they...
Medilink North of England provides a structured market‑access offering that helps MedTech and digital‑health innovators move beyond regulatory clearance to achieve commercial adoption in overseas health systems. The service is built around five pillars—market segmentation, global strategy, regulatory documentation, reimbursement...
Professor Segun Fatumo highlights the stark under‑representation of African genomes in global research, where over 86% of GWAS participants are of European ancestry despite Africa housing the greatest genetic diversity. He explains how this gap limits the accuracy of polygenic...
Healthcare providers are drowning in ever‑growing patient records, leading to missed follow‑ups, delayed appointments, and staff burnout. MVSPlus offers a dedicated virtual assistant that cleans, updates, and organizes charts in real time, integrating seamlessly with existing workflows. By handling routine...
Researchers identified interferon regulatory factor 7 (IRF7) as a master transcriptional driver that pushes vascular smooth muscle cells (SMCs) into a pro‑inflammatory, macrophage‑like state, a key step in plaque destabilisation. Single‑cell RNA sequencing and trajectory analysis uncovered an intermediate stem‑endothelial‑monocyte...
Novartis announced that its oral BTK inhibitor Rhapsido (remibrutinib) achieved significantly higher complete response rates than placebo in the phase 3 RemIND trial for the three most common forms of chronic inducible urticaria (CINDU). The drug, already approved for chronic spontaneous...
A “Variant of Unknown Significance” is a genetic finding that can’t yet be interpreted, leaving families with uncertainty instead of answers. Now, AI agents can help connect sequencing data with scientific literature and biological context to turn VUS into traceable, evidence-backed...
The Association for Diagnostics & Laboratory Medicine (ADLM) has issued a position statement urging Congress and federal regulators to update the Clinical Laboratory Improvement Amendments (CLIA) to explicitly govern AI tools used in clinical laboratories. ADLM warns that without modernized...
In this brief clip, host David Williams talks with Dr. Sarah Matt about the critical role of explainability in building trust for AI-driven healthcare. Dr. Matt emphasizes that patients and providers must understand how AI models make decisions to feel...
Korsana Biosciences announced a $175 million financing round led by Fairmount, Venrock, Wellington Management and TCGX to develop its Alzheimer’s antibody candidate KRSA‑028. The startup positions KRSA‑028 as a next‑generation “brain shuttle” designed to clear amyloid plaques more efficiently than existing...
![[Clinical Rounds] A Multidisciplinary Management Approach to Cervical Cancer During Pregnancy](/cdn-cgi/image/width=1200,quality=75,format=auto,fit=cover/https://hixhlmpcokxhartfkpyi.supabase.co/storage/v1/object/public/images/thumbnails/5281f8873aca1a3c24d65c4c50a98a5f.webp)
A 39‑year‑old gravida 3 woman presented at 10 weeks gestation with vaginal bleeding and a prior diagnosis of high‑grade squamous intraepithelial lesion (HSIL) that had not been followed up. Cervical cancer testing confirmed HSIL while the intrauterine pregnancy remained viable. The...
Epetōme, the UK‑based gut‑health brand founded by nutritionist Emily English, has secured a multi‑million‑pound investment led by Active Partners and Redrice Ventures. The funding will accelerate its international rollout and fund expanded clinical trials on probiotics and prebiotics. Since its...
Carterra unveiled Vega, the industry’s first 48‑channel high‑throughput SPR platform, delivering roughly 12‑fold higher screening capacity for small‑ and large‑molecule drug candidates. Covaris introduced the truCOVER® Total RNA Library Prep Kit, enabling robust RNA‑seq libraries from as little as 10 ng...
The FDA removed a consumer webpage that warned against chlorine dioxide, raw camel milk, chelation and hyperbaric oxygen as ineffective autism treatments, citing a routine cleanup of outdated content. The page, unchanged since 2019, remains only via the Internet Archive,...
Immedica’s pegzilarginase (Loargys), the first enzyme replacement therapy for arginase‑1 (ARG1) deficiency, has received NICE endorsement for NHS use in the UK. The weekly IV or subcutaneous treatment cuts blood arginine levels by roughly 80% and is recommended for patients...
The UK government, via Innovate UK, has launched a £20 million funding programme to accelerate development of medicines, medical devices, wearables, virtual‑reality therapies and AI‑enabled tools for drug and alcohol addiction. Grants of up to £10 million for late‑stage projects and up to...
Portal Diabetes has secured FDA breakthrough device designation for its implantable Portal Pump, an insulin delivery system that pairs an abdominal pump with continuous glucose monitoring and concentrated insulin. The company also launched a Phase I study of temperature‑stable Portal Insulin...
Janux Therapeutics has dosed the first participant in a Phase I, open‑label, dose‑escalation trial of JANX011, its inaugural candidate from the adaptive immune response modulator (ARM) platform. The bispecific antibody targets CD19‑expressing B cells to achieve a deep, lasting immune reset...
Johnson & Johnson received FDA approval for a once‑monthly subcutaneous regimen of Rybrevant Faspro combined with Lazertinib for first‑line treatment of advanced EGFR‑mutated non‑small cell lung cancer. The new schedule delivers clinical outcomes comparable to the earlier bi‑weekly dosing while preserving...
Barcelona is emerging as a premier European life‑sciences hub, contributing 7.6 % of Catalonia’s GDP and ranking sixth in scientific output. Six local biotech firms—Accure Therapeutics, Oryzon Genomics, SpliceBio, Peptomyc, Ona Therapeutics and Integra Therapeutics—are advancing diverse modalities from small‑molecule neuroprotectors...
Orthalis, backed by private equity firm Extens, announced the acquisition of Dentalsoft, a specialist orthodontic software provider. The purchase creates a new entity, SignalSoft Développement, focused on delivering software services to orthodontic professionals. By integrating Dentalsoft’s tools, Orthalis expands its...
In a new study, authors created a physician-validated benchmark spanning 10 text-based and multimodal tasks, against which they evaluated leading large language models (LLMs). "Then, we developed “Dr. CaBot,” an AI discussant designed to produce written and slide-based video presentations...
Researchers at KAIST unveiled an AI‑driven method that extracts wavelength‑dependent information from standard optical coherence tomography (OCT) to automatically detect lipid‑rich coronary plaques. The weakly supervised deep‑learning model learns from frame‑level labels, eliminating the need for pixel‑wise annotations and works...
Collegium Pharmaceutical (NASDAQ:COLL) saw Truist Securities lift its price target to $58 and reaffirm a Buy rating, citing a strong pain‑management portfolio and growing momentum for its extended‑release opioid, Jornay PM. The company released its 2026 outlook, projecting total product revenue...
UCLA researchers have engineered lipid nanoparticles to co‑deliver CRISPR/Cas9 components and a full‑length CFTR gene, achieving precise, mutation‑agnostic insertion in human airway cells. The non‑viral system corrected 3‑4% of cells yet restored up to 100% of normal chloride channel function,...
Researchers at Texas A&M have created injectable nanocomposite hemostats that cut blood clotting time from six‑seven minutes to one‑two minutes, slashing bleeding duration by up to 70% in internal hemorrhage models. The devices combine clay‑derived nanosilicates with a shape‑memory foam...
Amneal Pharmaceuticals (AMRX) was added to the S&P SmallCap 600 Index on Jan. 29, giving the company heightened investor exposure. JP Morgan subsequently raised its price target by $4 while keeping a Buy rating, signaling analyst confidence. The firm also announced a...
Bank of America raised its price target for Zoetis Inc. (ZTS) to $140 from $135 while maintaining a Neutral rating, citing the company’s strong fourth‑quarter 2025 results and an upbeat fiscal 2026 outlook. Zoetis reported adjusted EPS of $1.48, topping...
Researchers at St. Jude Children’s Research Hospital introduced M‑PACT, an AI‑driven liquid‑biopsy platform that classifies pediatric brain tumors from cerebrospinal fluid with 92% accuracy. The deep neural network was trained on over 5,000 DNA methylation profiles covering about 100 tumor...
In this third episode of his four‑part series, Roger Whitney guides listeners through practical ways to lower health‑care costs before Medicare, from daily health habits to smart insurance shopping. He demystifies the ACA premium subsidy system now that the expanded...
A lot of people don't even know they have high blood pressure, while over 200 million people wear an Apple Watch. The bridge between the two is whether an Apple Watch can properly detect hypertension. A new JAMA study aimed...
ScribeRyte AI introduced ClickNote, a free Chrome extension that automatically inserts AI‑generated SOAP notes into any browser‑based EMR. The tool leverages ambient speech technology, multilingual support, and HIPAA‑secure protocols to streamline documentation. ScribeRyte claims providers can reclaim up to ten...
Kipu Health announced Elevate 2026, a three‑day customer conference in Carlsbad, California, showcasing its AI‑native Kipu Helix Intelligent Operating System for behavioral health. The event gathers executives, operators and administrators to explore AI‑driven strategies, hands‑on programming and peer insights. Kipu...
Routes Healthcare, a leading health and social care provider in northern England, adopted the BPA Platform to integrate its Sage 200 ERP with a wide range of SaaS applications. The low‑code integration layer unified data, automated workforce communication, recruitment, and...
This is the kind of AI that moves me. After 18 years of silence, Ann spoke again. A brain implant reads signals from her speech cortex. AI decodes them in real time. A digital avatar restores her voice and facial expressions. What’s new? Not text on...
#FDA backs down on #Moderna: The agency had refused to review the company's licensure application for an mRNA flu vaccine, but after significant pushback has relented. https://t.co/omo7bEBQGW
Doncaster and Bassetlaw Teaching Hospitals NHS Foundation Trust will pilot CardMedic, a clinically validated communication app, for twelve months starting with a soft launch in October across four key departments. The charity‑funded initiative aims to eliminate language, visual, hearing and...
$MRNA says FDA will now review its flu vaccine. PDUFA date is Aug. 5. https://t.co/npZzeEa5nk
FDA agrees to review Moderna flu vaccine application, splitting review into standard approval for those under 65 and accelerated approval for those 65 and above. $mrna https://t.co/HMMlPm0PGh
The NHS Business Services Authority (NHSBSA) has completed a beta reassessment of its Baby Loss Certificate service, achieving compliance with all 14 government service standards. The digital service, created after the Pregnancy Loss Review, now offers bereaved parents formal recognition...
AI medical advice: Not ready for prime time. A study by the Icahn School of Medicine at Mount Sinai, published in The Lancet Digital Health, reveals vulnerabilities in medical AI systems. https://t.co/ArD323yhzL #research #AI #healthcare #medicine
TheKey, a Delray, Florida‑based home‑care provider, is moving to add private‑pay nursing services in four new states, aiming for a total of six states by the end of 2026. The company is finalizing licensure for the southern half of California...
Regulatory uncertainty is rising as the FDA shifts leadership, adopts a single‑trial approval pathway, and tightens its benefit‑risk framework. While the one‑trial standard promises faster, cheaper market entry, recent surprise complete response letters (CRLs) show that even successful Phase 3 results...
